Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) ...

When it comes to HIV prevention, few tools have been as game-changing as PrEP — short for pre-exposure prophylaxis. Yet, despite its effectiveness, many people still aren’t sure whether it’s right for ...

Lenacapavir, a twice-yearly injectable antiretroviral, reduced the risk of HIV infection by 96% in a large study of gay and bisexual men and gender diverse people, according to a Gilead Sciences ...

Gay and bisexual men who are at risk for HIV infection should consider using antiretroviral drugs for pre-exposure prophylaxis, better known as PrEP, according to new guidelines from the World Health ...

June 17, 2022 – Many male couples in the U.S. seem to be underestimating the effectiveness of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, and educating partners together could improve the ...

Please provide your email address to receive an email when new articles are posted on . Most study participants were satisfied with long-acting PrEP and said they would recommend it to friends. A long ...

Young men who have sex with men (YMSM) said the treatment’s efficacy was the most important feature injectable HIV pre-exposure prophylaxis (PrEP), over side effects, cost, protection duration, and ...

Bisexual men encounter unique sexual health risks due to their sexual relationships with both men and women. This dual-risk exposure can sometimes lead to higher rates of STIs, including HIV, herpes, ...

Twice-yearly lenacapavir (Sunlenca) substantially reduced HIV infection when used for preexposure prophylaxis (PrEP) in cisgender men and transgender or gender-nonbinary persons in the pivotal PURPOSE ...